Drug Shortage Report for PLAVIX

Last updated on 2023-02-15 History
Report ID 184405
Drug Identification Number 02238682
Brand name PLAVIX
Common or Proper name Plavix 75mg
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) CLOPIDOGREL
Strength(s) 75MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size Blister of 28 Tablets
ATC code B01AC
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2023-02-06
Estimated end date 2023-03-06
Actual end date 2023-02-14
Shortage status Resolved
Updated date 2023-02-15
Company comments Manufacturing delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2023-02-15 English Compare
v5 2023-02-14 French Compare
v4 2023-02-14 English Compare
v3 2023-02-10 French Compare
v2 2023-02-10 English Compare
v1 2023-02-10 English Compare

Showing 1 to 6 of 6